Figure (Rop09 0001 01)
Ropivacaine Hydrochloride Injection, Solution
Product Images NDC 65219-632
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 65219-632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fresenius Kabi Logo (Rop09 0001 02)
Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Bag Label)
This is a prescription medication called Ropivacaine Hydrochloride Injection, USP. It is a solution containing 0.2% Ropivacaine HCI (200 mg per 100 mL) for Infiltration, Nerve Block, and Epidural Administration. Each mL contains 2 mg of Ropivacaine HCI and 8.6 mg of sodium chloride. The pH of the solution is adjusted to 4.0 to 6.0 using sodium hydroxide and/or hydrochloric acid. It does not contain preservatives and should be used immediately after opening. The medication is stored at 20° to 25°C (68° to 77°F). The container is latex and PVC-free. Dosage information can be found in the package insert. Made for Fresenius Kabi in India.*
Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Overpouch Label)
This is a description of Ropivacaine Hydrochloride Injection, USP, containing 200 mg per 100 mL (2 mg per mL) for Infiltration, Nerve Block, and Epidural Administration Only. Each mL includes Ropivacaine HCI and sodium chloride, with no preservatives. The pH is adjusted to 4.0 to 6.0 using sodium hydroxide and/or hydrochloric acid. It should be used immediately after opening and any unused portion should be discarded. It is stored at 20° to 25°C and is for single-dose only. The packaging includes an overwrap and inner bag, both for maintaining sterility. Produced by Fresenius Kabi in India. More detailed information can be found in the package insert.*
Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Bag Label)
This text is a label for Ropivacaine Hydrochloride injection, USP. The injection contains 400 mg per 200 mL (2 mg per mL) and is indicated for Infiltration, Nerve Block, and Epidural Administration Only. It does not contain preservatives and should be used immediately after opening. The storage temperature is recommended to be at 20° to 25°C (68° to 77°F). The container is sterile and single-dose, and any unused portion should be discarded. This product is manufactured by Fresenius Kabi in Lake Zurich, IL, and is made in India. The dosage instructions can be found in the package insert.*
Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Overpouch Label)
This is a description of Ropivacaine Hydrochloride Injection, USP containing 400 mg per 200 mL (2 mg per mL) for Infiltration, Nerve Block, and Epidural Administration Only. Each mL contains Ropivacaine HCI 2 mg and sodium chloride 8.6 mg. It is a single-dose medication with instructions to discard any unused portion and to use immediately after opening. The medication does not contain preservatives and needs to be stored at 20° to 25°C (68° to 77°F). The packaging includes an overwrap that acts as a moisture barrier to maintain sterility. The product is manufactured for Fresenius Kabi and made in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
